Gen-Probe (GPRO) announced that it has completed its acquisition of Prodesse, Inc., a leader in molecular testing for influenza and other infectious diseases, for approximately $60 million in cash.
Gen-Probe's purchase price could increase to up to $85 million if Prodesse achieves certain financial and regulatory milestones in 2010 and 2011.
Excluding the charges, Gen-Probe expects the acquisition to add approximately $0.05 to the Company's 2010 earnings per share, based on about $15 million in total revenues. Gen-Probe expects to update its 2009 financial guidance to include the effects of the acquisition in its third quarter earnings release on October 29.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.